Gelion PLC GELN

Cordiant Digital Infrastructure Ltd (LSE:CORD, FRA:86L) says booming AI demand is starting to convert into real contracted revenue. Quarterly revenue jumped over 20%, with a pipeline worth potentially over £1 billion. Digitalbox PLC (AIM:DBOX, FRA:RLXB) is pushing into original video with a growing creator network. It's aiming to hit around 500 videos a month by October as it responds to a turbulent first half. Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF, FRA:VD5N) says second-quarter production from its non- operated US portfolio beat forecasts, up around 45% year on year. Its lender's also reaf

Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) told investors it has secured six patents covering key elements of its lithium-sulfur battery technology as it pushes ahead with commercialisation and a planned expansion into the US market. The patents comprise three grants in the United States, two...

Chesnara PLC (LSE:CSN) saw operating capital generation jump 79% to £96 million in the first half.  CEO Steve Murray also highlighted the group's 185% solvency coverage ratio and an active acquisition pipeline. Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) has raised £1.3 million to push forward its CNS drug pipeline.  That includes trials for alcohol use disorder and addiction treatments. hVIVO PLC (AIM:HVO) has bought CRS Berlin to expand into dermatology and women's health trials.  The CEO says it opens up new markets and cross-selling opportunities in Germany. Gelion PLC (AIM:GELN, OTC:G

Faron Pharmaceuticals Limited (AIM:FARN) is set to start its phase IIb BEXERA trial for blood cancer drug bexmarilimab in the second half of this year. It'll test the drug in 90 patients across the US, Europe and the UK, funded by a €40 million rights issue. Central Asia Metals PLC (AIM:CAML, OTC:CAMLF) has nearly doubled first-half earnings on higher copper and zinc prices plus higher output. Profit before tax jumped 203%, and the interim dividend's been lifted to 8p. Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) has completed drone testing with QinetiQ on its sulfur battery cathode material. Cel

Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S), the sulfur battery technology company, has completed a government-backed programme in which its cathode material passed independent drone mission testing carried out by QinetiQ Group PLC (LSE:QQ.). The cells, built and evaluated by the UK defence,...

Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) CEO Matthew Wood spoke with Proactive's Stephen Gunnion about the successful completion of drone mission testing with QinetiQ, highlighting the performance of Gelion's nano-encapsulated sulfur (NES) cathode material in lithium-sulfur cells. QinetiQ independently built and tested pouch cells using Gelion's NES cathode paired with lithium metal anodes, as part of the Advanced Route to Market Demonstrator 4 (ARMD4) programme funded by the UK's Advanced Propulsion Centre. The cells completed representative drone mission simulations, including repeated vert

Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) CEO Matthew Wood spoke with Proactive's Stephen Gunnion about the company's newly announced funded development and scale-up agreement with Mitsui Kinzoku, and how it fits into Gelion's wider strategy for its Nano-Encapsulated Sulfur (NES) cathode technology. Mitsui Kinzoku, a leading Japanese supplier of metals and engineered materials with an established position in advanced battery materials, will work with Gelion to validate its sulfur-based NES cathode material in both liquid and solid-state battery cells. The agreement includes £2 million of non-d

Smaller defense contractors often attract little analyst coverage, leaving pricing less crowded and research gaps wider. Three names from the screener pair mission-critical roles with high-risk, high-potential stories that could reward a closer look.

EnergyPathways PLC (AIM:EPP) has formally accepted the gas storage licence for its MESH project and launched the next phase of development. The company is targeting a final investment decision in 2028, with commercial operations planned for 2031. Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) says a retail offer, alongside an institutional placing, will help fund the commercial rollout of its Stereax and Goliath batteries. The funding supports customer validation, product deliveries and the next stage of Goliath development. Metals One PLC (AIM:MET1, FRA:HT7, OTCQB:MTOPF) has increased its stake in

Gelion (AIM:GELN) chairman Dr Steve Mahon and new CEO Matthew Wood joined Proactive's Stephen Gunnion to discuss the company's entry into the US market, Wood's appointment, and growing commercial opportunities for its sulfur battery technology. Wood explained that new agreements with the Department of Energy's National Laboratory of the Rockies mark Gelion's first step into the US, opening commercial and defence opportunities in the world's largest battery market amid rising demand for alternatives to Chinese supply chains. Mahon discussed the board's decision to appoint Wood after an internat

Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S), the sulfur battery company, has appointed Matthew Wood as chief executive as it shifts from technology development towards commercial scale-up. He replaces John Wood, who retires from his full-time executive role with immediate effect and steps down...

Optima Health PLC (AIM:OPT, OTC:OHLTF, FRA:J3N) has lifted full-year revenue by around 15% to roughly £121 million, with adjusted EBITDA coming in around 10% ahead of expectations. In a trading update, the company said its £100 million acquisition of PAM Healthcare is already delivering, with £1.3 million of annualised cost synergies achieved by June. IP Group PLC (LSE:IPO) says portfolio company Istesso has begun dosing patients in a phase II trial of leramistat for muscle loss caused by rheumatoid arthritis. CEO Greg Smith calls it an important inflexion point, with the drug showing the pote

Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) said it has signed an exclusive commercial licence agreement with Max-Planck-Innovation GmbH, giving the company long-term global rights to intellectual property covering nano-encapsulated sulfur cathode technology and novel nano-confined anode...

Longspur Research has initiated coverage of Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S), the battery materials company, with a central case valuation of 153p per share, representing nearly eight times the current share price of 19.25p. The broker's bullish case rests on Gelion's proprietary...

Shares in Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S), the sulfur battery company, rose 16% to 20.52p after it announced a three-year collaboration with Nissan and the University of Oxford to develop next-generation solid-state electric vehicle batteries using its proprietary Nano-Encapsulated...

Arecor Therapeutics PLC (AIM:AREC) says talks are progressing on a broader partnership for its lead insulin candidate AT278. Releasing its 2025 annual results, the Cambridge-based diabetes biotech said a phase II trial is targeted for the second half of this year. Great Southern Copper PLC (LSE:GSCU, FRA:E9E) has expanded its footprint at the La Colorada prospect in Chile. Five new concessions add 1,000 hectares to what looks like a significant copper-gold target. Powerhouse Energy Group PLC (AIM:PHE, FRA:BT81) has granted a non-exclusive licence of its waste-to-energy technology to Hydrogen U

Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) this week outlined progress in its battery technology development and an expanded collaboration with TDK, as chief technology officer Louis Adriaenssens detailed the significance of recent announcements. Adriaenssens said the company has successfully...

Sunda Energy PLC (AIM:SNDA) has made a transformational acquisition in New Zealand, giving it immediate production of over 1,000 barrels a day. The deal adds a third pillar to its portfolio alongside assets in Timor-Leste and the Philippines. Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) has expanded its partnership with TDK Corporation, successfully moving its battery cathode technology into a pouch cell format. TDK dominates the drone battery market, and prototype results are expected soon. Coiled Therapeutics (AIM:COIL) has reported a jump in clinical benefit rate from 40% to 80% for its cancer

Gelion PLC (AIM:GELN) chief technology officer Louis Adriaenssens joined Proactive's Stephen Gunnion to explain why the company's expanded collaboration with TDK Corporation could be a defining moment for its NES cathode technology. Adriaenssens revealed how Gelion has successfully transferred its technology into a pouch cell format, a critical step on the road to commercialisation, and why its cathode works seamlessly with standard lithium-ion components already used in mass manufacturing. With TDK dominant in the drone battery market and a major force in consumer electronics, this partnershi